ワクチン世界市場規模調査, タイプ別(結合型ワクチン, 不活性化およびサブユニット型ワクチン,弱毒生ワクチン, 組み換えワクチン, 毒素ワクチン), 技術別(一価ワクチン, 多価ワクチン), 疾患別(肺炎球菌疾患, DTP, インフルエンザ, HPV, 髄膜炎菌疾患, ロタウイルス, 肝炎, MMR, 水痘, 帯状疱疹, その他), 適応症別, (肺炎, インフルエンザ, インフルエンザ, ロタウイルス, ポリオ, その他)。ポリオ、ロタウイルス、肝炎、MMR、水痘、帯状疱疹、その他の適応症)、投与経路(筋肉内および皮下投与、経口投与、その他の投与経路)、患者タイプ(小児患者、成人患者)、地域予測 2022-2028年Global Vaccines Market Size study, By Type (Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines), By Technology (Monovalent vaccines, Multivalent vaccines), By Disease Indication (Pneumococcal disease, DTP, Influenza, HPV, Meningococcal disease, Polio, Rotavirus, Hepatitis, MMR, Varicella, Herpes zoster, Other disease indications), By Route of Administration (Intramuscular and subcutaneous administration, Oral administration, Other routes of administration), By Patient Type (Pediatric patients, Adult patients), and Regional Forecasts 2022-2028 世界のワクチン市場は、2021年に約477億4000万米ドルと評価され、予測期間2022-2028年には7.0%を超える健全な成長率で成長すると予測されています。ワクチンとは、特定の感染症に対する強力な獲得免疫を提供する... もっと見る
サマリー世界のワクチン市場は、2021年に約477億4000万米ドルと評価され、予測期間2022-2028年には7.0%を超える健全な成長率で成長すると予測されています。ワクチンとは、特定の感染症に対する強力な獲得免疫を提供する生物学的製剤です。ワクチンは、抗体の生成を促進し、1つまたは複数の疾患に対する免疫力を提供するために使用されます。ワクチンは、病気を引き起こす微生物を模倣した物質で構成され、通常、衰弱または死滅した微生物、その毒素、またはその表面タンパク質の1つから生成されます。新興・再興感染症の増加、予防接種プログラムの重視、ワクチン開発に対する政府の支援の増加、ワクチン研究開発活動を強化するための業界の取り組みが、世界中で市場需要を急増させる主な要因となっています。例えば、ユニセフによると、2019年11月に、トンガ、サモア、フィジーで麻疹を予防するために約26万回のワクチン接種が行われました。しかし、ワクチン開発の高コストが、2022-2028年の予測期間における市場の成長を阻害しています。また、治療用ワクチンへの傾倒の高まりは、予測期間中の市場需要の触媒として作用すると予測されます。ワクチンの世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、ヨーロッパ、中南米、その他の地域です。北米は、ワクチン開発のための様々な非政府組織や政府組織による投資の増加や感染症の高い流行により、市場シェアの面で世界の主要地域となっています。一方、アジア太平洋地域は、2022年から2028年の予測期間において、最も高いCAGRを示すと予想されています。政府のイニシアチブの高まり、医療費の増加、大規模な患者人口の存在などの要因は、アジア太平洋地域のワクチン市場に有利な成長見通しを生み出すでしょう。 本レポートに含まれる主な市場参加者は以下の通りです。 グラクソ・スミスクライン plc ファイザー サノフィパスツール メルク・アンド・カンパニー、Inc. CSLリミテッド エマージェント・バイオソリューションズ社 ジョンソン・エンド・ジョンソン セラムインスティテュートオブインディアPVT Ltd. 田辺三菱製薬株式会社 パナシアバイオテック 本調査の目的は、近年における様々なセグメントおよび国の市場規模を定義し、今後8年間の値を予測することです。本レポートは、調査対象となる各地域および各国における産業の質的および量的な側面を取り入れるよう設計されています。さらに、市場の将来的な成長を規定する駆動因子や課題などの重要な側面に関する詳細な情報も提供しています。さらに、本レポートでは、主要企業の競争環境と製品タイプの詳細な分析とともに、利害関係者が投資するためのミクロ市場における利用可能な機会も盛り込まなければなりません。市場の詳細なセグメントとサブセグメントを以下に説明します。 タイプ別 コンジュゲートワクチン 不活性化ワクチンおよびサブユニットワクチン 弱毒生ワクチン 遺伝子組換えワクチン トキソイドワクチン 技術別 一価ワクチン 多価ワクチン 疾患別適応症 肺炎球菌 DTP インフルエンザ HPV 髄膜炎菌感染症 ポリオ ロタウイルス 肝炎 MMR 水痘(みずぼうそう 帯状疱疹 その他の適応症 投与経路別 筋肉内投与、皮下投与 経口投与 その他の投与経路 患者タイプ別 小児 成人 地域別 北米 米国 カナダ 欧州 英国 ドイツ フランス スペイン イタリア ROE アジア太平洋地域 中国 インド 日本 オーストラリア 韓国 ロアパック ラテンアメリカ ブラジル メキシコ その他の地域 さらに、調査のために考慮した年は以下の通りです。 過去年 - 2018年、2019年、2020年 基準年 - 2021年 予測期間 - 2022年~2028年 市場調査における世界のワクチン市場のターゲットオーディエンス。 主要コンサルティング会社・アドバイザー 大企業、中堅企業、中小企業 ベンチャーキャピタル 付加価値再販業者(VAR) サードパーティー・ナレッジ・プロバイダー 投資銀行家 投資家 目次Chapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion) 1.2.1. Vaccines Market, by Region, 2020-2028(USD Billion) 1.2.2. Vaccines Market, by Type, 2020-2028(USD Billion) 1.2.3. Vaccines Market, by Technology, 2020-2028(USD Billion) 1.2.4. Vaccines Market, by Disease Indication, 2020-2028(USD Billion) 1.2.5. Vaccines Market, by Route of Administration, 2020-2028(USD Billion) 1.2.6. Vaccines Market, by Patient Type, 2020-2028(USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Vaccines Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Vaccines Market Dynamics 3.1. Vaccines Market Impact Analysis (2020-2028) 3.1.1. Market Drivers 3.1.1.1. Growing prevalence of emerging and re-emerging infectious diseases 3.1.1.2. Increasing government support for vaccine development 3.1.2. Market Challenges 3.1.2.1. High cost of vaccine development 3.1.3. Market Opportunities 3.1.3.1. Rising inclination on therapeutic vaccines Chapter 4. Global Vaccines Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion 4.5. Top investment opportunity 4.6. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1.1. Assessment of the overall impact of COVID-19 on the industry 5.1.2. Pre COVID-19 and post COVID-19 market scenario Chapter 6. Global Vaccines Market, by Type 6.1. Market Snapshot 6.2. Global Vaccines Market by Type, Performance - Potential Analysis 6.3. Global Vaccines Market Estimates & Forecasts by Type, 2019-2028 (USD Billion) 6.4. Vaccines Market, Sub Segment Analysis 6.4.1. Conjugate Vaccines 6.4.2. Inactivated and Subunit Vaccines 6.4.3. Live Attenuated Vaccines 6.4.4. Recombinant Vaccines 6.4.5. Toxoid Vaccines Chapter 7. Global Vaccines Market, by Technology 7.1. Market Snapshot 7.2. Global Vaccines Market by Technology, Performance – Potential Analysis 7.3. Global Vaccines Market Estimates & Forecasts by Technology, 2019-2028 (USD Billion) 7.4. Vaccines Market, Sub Segment Analysis 7.4.1. Monovalent vaccines 7.4.2. Multivalent vaccines Chapter 8. Global Vaccines Market, by Disease Indication 8.1. Market Snapshot 8.2. Global Vaccines Market by Disease Indication, Performance - Potential Analysis 8.3. Global Vaccines Market Estimates & Forecasts by Disease Indication, 2019-2028 (USD Billion) 8.4. Vaccines Market, Sub Segment Analysis 8.4.1. Pneumococcal disease 8.4.2. DTP 8.4.3. Influenza 8.4.4. HPV 8.4.5. Meningococcal disease 8.4.6. Polio 8.4.7. Rotavirus 8.4.8. Hepatitis 8.4.9. MMR 8.4.10. Varicella 8.4.11. Herpes zoster 8.4.12. Other disease indications Chapter 9. Global Vaccines Market, by Route of Administration 9.1. Market Snapshot 9.2. Global Vaccines Market by Route of Administration, Performance - Potential Analysis 9.3. Global Vaccines Market Estimates & Forecasts by Route of Administration, 2019-2028 (USD Billion) 9.4. Vaccines Market, Sub Segment Analysis 9.4.1. Intramuscular and subcutaneous administration 9.4.2. Oral administration 9.4.3. Other routes of administration Chapter 10. Global Vaccines Market, by Patient Type 10.1. Market Snapshot 10.2. Global Vaccines Market by Patient Type, Performance - Potential Analysis 10.3. Global Vaccines Market Estimates & Forecasts by Patient Type, 2019-2028 (USD Billion) 10.4. Vaccines Market, Sub Segment Analysis 10.4.1. Pediatric patients 10.4.2. Adult patients Chapter 11. Global Vaccines Market, Regional Analysis 11.1. Vaccines Market, Regional Market Snapshot 11.2. North America Vaccines Market 11.2.1. U.S. Vaccines Market 11.2.1.1. Type breakdown estimates & forecasts, 2019-2028 11.2.1.2. Technology breakdown estimates & forecasts, 2019-2028 11.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2028 11.2.1.4. Route of Administration breakdown estimates & forecasts, 2019-2028 11.2.1.5. Patient Type breakdown estimates & forecasts, 2019-2028 11.2.2. Canada Vaccines Market 11.3. Europe Vaccines Market Snapshot 11.3.1. U.K. Vaccines Market 11.3.2. Germany Vaccines Market 11.3.3. France Vaccines Market 11.3.4. Spain Vaccines Market 11.3.5. Italy Vaccines Market 11.3.6. Rest of Europe Vaccines Market 11.4. Asia-Pacific Vaccines Market Snapshot 11.4.1. China Vaccines Market 11.4.2. India Vaccines Market 11.4.3. Japan Vaccines Market 11.4.4. Australia Vaccines Market 11.4.5. South Korea Vaccines Market 11.4.6. Rest of Asia Pacific Vaccines Market 11.5. Latin America Vaccines Market Snapshot 11.5.1. Brazil Vaccines Market 11.5.2. Mexico Vaccines Market 11.6. Rest of The World Vaccines Market Chapter 12. Competitive Intelligence 12.1. Top Market Strategies 12.2. Company Profiles 12.2.1. GlaxoSmithKline plc 12.2.1.1. Key Information 12.2.1.2. Overview 12.2.1.3. Financial (Subject to Data Availability) 12.2.1.4. Type Summary 12.2.1.5. Recent Developments 12.2.2. Pfizer, Inc. 12.2.3. Sanofi Pasteur 12.2.4. Merck & Co., Inc. 12.2.5. CSL Limited 12.2.6. Emergent BioSolutions, Inc. 12.2.7. Johnson & Johnson 12.2.8. Serum Institute of India Pvt. Ltd. 12.2.9. Mitsubishi Tanabe Pharma Corporation 12.2.10. Panacea Biotec Chapter 13. Research Process 13.1. Research Process 13.1.1. Data Mining 13.1.2. Analysis 13.1.3. Market Estimation 13.1.4. Validation 13.1.5. Publishing 13.2. Research Attributes 13.3. Research Assumption List of Tables TABLE 1. Global Vaccines market, report scope TABLE 2. Global Vaccines market estimates & forecasts by Region 2019-2028 (USD Billion) TABLE 3. Global Vaccines market estimates & forecasts by Type 2019-2028 (USD Billion) TABLE 4. Global Vaccines market estimates & forecasts by Technology 2019-2028 (USD Billion) TABLE 5. Global Vaccines market estimates & forecasts by Disease Indication 2019-2028 (USD Billion) TABLE 6. Global Vaccines market estimates & forecasts by Route of Administration 2019-2028 (USD Billion) TABLE 7. Global Vaccines market estimates & forecasts by Patient Type 2019-2028 (USD Billion) TABLE 8. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 9. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 10. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 11. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 12. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 13. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 14. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 15. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 16. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 17. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 18. U.S. Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 19. U.S. Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 20. U.S. Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 21. Canada Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 22. Canada Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 23. Canada Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 24. UK Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 25. UK Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 26. UK Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 27. Germany Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 28. Germany Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 29. Germany Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 30. RoE Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 31. RoE Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 32. RoE Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 33. China Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 34. China Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 35. China Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 36. India Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 37. India Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 38. India Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 39. Japan Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 40. Japan Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 41. Japan Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 42. RoAPAC Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 43. RoAPAC Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 44. RoAPAC Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 45. Brazil Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 46. Brazil Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 47. Brazil Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 48. Mexico Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 49. Mexico Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 50. Mexico Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 51. RoLA Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 52. RoLA Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 53. RoLA Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 54. Row Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 55. Row Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 56. Row Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 57. List of secondary sources, used in the study of global Vaccines market TABLE 58. List of primary sources, used in the study of global Vaccines market TABLE 59. Years considered for the study TABLE 60. Exchange rates considered
SummaryGlobal Vaccines Market is valued at approximately USD 47.74 billion in 2021and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2022-2028. A vaccine is a biological product that offers vigorous acquired immunity to a specific infectious disease. A vaccine is used to boost the creation of antibodies and deliver immunity against one or several diseases. It comprises an agent that mimics a disease-causing microorganism and is usually produced from a debilitated or killed form of the microbe, its toxins, or one of its surface proteins. The growing occurrence of emerging and re-emerging infectious diseases, rising focus on immunization programs, increasing government support for vaccine development, and rising industry initiatives to augment vaccine R&D activities are the chief factors that may surge the market demand across the globe. For instance, as per the UNICEF, in November 2019, about 260,000 vaccination doses were delivered to prevent measles in Tonga, Samoa, and Fiji. However, the high cost of vaccine development impedes the growth of the market over the forecast period of 2022-2028. Also, the rising inclination on therapeutic vaccines is anticipated to act as a catalyzing factor for the market demand during the forecast period. Table of ContentsChapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion) 1.2.1. Vaccines Market, by Region, 2020-2028(USD Billion) 1.2.2. Vaccines Market, by Type, 2020-2028(USD Billion) 1.2.3. Vaccines Market, by Technology, 2020-2028(USD Billion) 1.2.4. Vaccines Market, by Disease Indication, 2020-2028(USD Billion) 1.2.5. Vaccines Market, by Route of Administration, 2020-2028(USD Billion) 1.2.6. Vaccines Market, by Patient Type, 2020-2028(USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Vaccines Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Vaccines Market Dynamics 3.1. Vaccines Market Impact Analysis (2020-2028) 3.1.1. Market Drivers 3.1.1.1. Growing prevalence of emerging and re-emerging infectious diseases 3.1.1.2. Increasing government support for vaccine development 3.1.2. Market Challenges 3.1.2.1. High cost of vaccine development 3.1.3. Market Opportunities 3.1.3.1. Rising inclination on therapeutic vaccines Chapter 4. Global Vaccines Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion 4.5. Top investment opportunity 4.6. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1.1. Assessment of the overall impact of COVID-19 on the industry 5.1.2. Pre COVID-19 and post COVID-19 market scenario Chapter 6. Global Vaccines Market, by Type 6.1. Market Snapshot 6.2. Global Vaccines Market by Type, Performance - Potential Analysis 6.3. Global Vaccines Market Estimates & Forecasts by Type, 2019-2028 (USD Billion) 6.4. Vaccines Market, Sub Segment Analysis 6.4.1. Conjugate Vaccines 6.4.2. Inactivated and Subunit Vaccines 6.4.3. Live Attenuated Vaccines 6.4.4. Recombinant Vaccines 6.4.5. Toxoid Vaccines Chapter 7. Global Vaccines Market, by Technology 7.1. Market Snapshot 7.2. Global Vaccines Market by Technology, Performance – Potential Analysis 7.3. Global Vaccines Market Estimates & Forecasts by Technology, 2019-2028 (USD Billion) 7.4. Vaccines Market, Sub Segment Analysis 7.4.1. Monovalent vaccines 7.4.2. Multivalent vaccines Chapter 8. Global Vaccines Market, by Disease Indication 8.1. Market Snapshot 8.2. Global Vaccines Market by Disease Indication, Performance - Potential Analysis 8.3. Global Vaccines Market Estimates & Forecasts by Disease Indication, 2019-2028 (USD Billion) 8.4. Vaccines Market, Sub Segment Analysis 8.4.1. Pneumococcal disease 8.4.2. DTP 8.4.3. Influenza 8.4.4. HPV 8.4.5. Meningococcal disease 8.4.6. Polio 8.4.7. Rotavirus 8.4.8. Hepatitis 8.4.9. MMR 8.4.10. Varicella 8.4.11. Herpes zoster 8.4.12. Other disease indications Chapter 9. Global Vaccines Market, by Route of Administration 9.1. Market Snapshot 9.2. Global Vaccines Market by Route of Administration, Performance - Potential Analysis 9.3. Global Vaccines Market Estimates & Forecasts by Route of Administration, 2019-2028 (USD Billion) 9.4. Vaccines Market, Sub Segment Analysis 9.4.1. Intramuscular and subcutaneous administration 9.4.2. Oral administration 9.4.3. Other routes of administration Chapter 10. Global Vaccines Market, by Patient Type 10.1. Market Snapshot 10.2. Global Vaccines Market by Patient Type, Performance - Potential Analysis 10.3. Global Vaccines Market Estimates & Forecasts by Patient Type, 2019-2028 (USD Billion) 10.4. Vaccines Market, Sub Segment Analysis 10.4.1. Pediatric patients 10.4.2. Adult patients Chapter 11. Global Vaccines Market, Regional Analysis 11.1. Vaccines Market, Regional Market Snapshot 11.2. North America Vaccines Market 11.2.1. U.S. Vaccines Market 11.2.1.1. Type breakdown estimates & forecasts, 2019-2028 11.2.1.2. Technology breakdown estimates & forecasts, 2019-2028 11.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2028 11.2.1.4. Route of Administration breakdown estimates & forecasts, 2019-2028 11.2.1.5. Patient Type breakdown estimates & forecasts, 2019-2028 11.2.2. Canada Vaccines Market 11.3. Europe Vaccines Market Snapshot 11.3.1. U.K. Vaccines Market 11.3.2. Germany Vaccines Market 11.3.3. France Vaccines Market 11.3.4. Spain Vaccines Market 11.3.5. Italy Vaccines Market 11.3.6. Rest of Europe Vaccines Market 11.4. Asia-Pacific Vaccines Market Snapshot 11.4.1. China Vaccines Market 11.4.2. India Vaccines Market 11.4.3. Japan Vaccines Market 11.4.4. Australia Vaccines Market 11.4.5. South Korea Vaccines Market 11.4.6. Rest of Asia Pacific Vaccines Market 11.5. Latin America Vaccines Market Snapshot 11.5.1. Brazil Vaccines Market 11.5.2. Mexico Vaccines Market 11.6. Rest of The World Vaccines Market Chapter 12. Competitive Intelligence 12.1. Top Market Strategies 12.2. Company Profiles 12.2.1. GlaxoSmithKline plc 12.2.1.1. Key Information 12.2.1.2. Overview 12.2.1.3. Financial (Subject to Data Availability) 12.2.1.4. Type Summary 12.2.1.5. Recent Developments 12.2.2. Pfizer, Inc. 12.2.3. Sanofi Pasteur 12.2.4. Merck & Co., Inc. 12.2.5. CSL Limited 12.2.6. Emergent BioSolutions, Inc. 12.2.7. Johnson & Johnson 12.2.8. Serum Institute of India Pvt. Ltd. 12.2.9. Mitsubishi Tanabe Pharma Corporation 12.2.10. Panacea Biotec Chapter 13. Research Process 13.1. Research Process 13.1.1. Data Mining 13.1.2. Analysis 13.1.3. Market Estimation 13.1.4. Validation 13.1.5. Publishing 13.2. Research Attributes 13.3. Research Assumption List of Tables TABLE 1. Global Vaccines market, report scope TABLE 2. Global Vaccines market estimates & forecasts by Region 2019-2028 (USD Billion) TABLE 3. Global Vaccines market estimates & forecasts by Type 2019-2028 (USD Billion) TABLE 4. Global Vaccines market estimates & forecasts by Technology 2019-2028 (USD Billion) TABLE 5. Global Vaccines market estimates & forecasts by Disease Indication 2019-2028 (USD Billion) TABLE 6. Global Vaccines market estimates & forecasts by Route of Administration 2019-2028 (USD Billion) TABLE 7. Global Vaccines market estimates & forecasts by Patient Type 2019-2028 (USD Billion) TABLE 8. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 9. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 10. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 11. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 12. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 13. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 14. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 15. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 16. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 17. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 18. U.S. Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 19. U.S. Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 20. U.S. Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 21. Canada Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 22. Canada Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 23. Canada Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 24. UK Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 25. UK Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 26. UK Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 27. Germany Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 28. Germany Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 29. Germany Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 30. RoE Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 31. RoE Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 32. RoE Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 33. China Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 34. China Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 35. China Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 36. India Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 37. India Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 38. India Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 39. Japan Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 40. Japan Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 41. Japan Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 42. RoAPAC Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 43. RoAPAC Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 44. RoAPAC Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 45. Brazil Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 46. Brazil Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 47. Brazil Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 48. Mexico Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 49. Mexico Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 50. Mexico Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 51. RoLA Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 52. RoLA Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 53. RoLA Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 54. Row Vaccines market estimates & forecasts, 2019-2028 (USD Billion) TABLE 55. Row Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 56. Row Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 57. List of secondary sources, used in the study of global Vaccines market TABLE 58. List of primary sources, used in the study of global Vaccines market TABLE 59. Years considered for the study TABLE 60. Exchange rates considered
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
Bizwit Research & Consulting LLP 社の最新刊レポート
本レポートと同じKEY WORD(administration)の最新刊レポート
よくあるご質問Bizwit Research & Consulting LLP社はどのような調査会社ですか?Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/19 10:28 144.64 円 160.77 円 193.27 円 |